$XYL
Xylem Inc.

2024 Q2 Form 10-Q Financial Statement

#000152447224000015 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $2.169B $2.033B $1.448B
YoY Change 25.96% 40.4% 13.84%
Cost Of Revenue $1.350B $1.281B $902.0M
YoY Change 26.05% 42.02% 12.05%
Gross Profit $819.0M $752.0M $546.0M
YoY Change 25.81% 37.73% 16.92%
Gross Profit Margin 37.76% 36.99% 37.71%
Selling, General & Admin $485.0M $474.0M $354.0M
YoY Change 19.16% 33.9% 16.45%
% of Gross Profit 59.22% 63.03% 64.84%
Research & Development $58.00M $59.00M $53.00M
YoY Change 0.0% 11.32% 1.92%
% of Gross Profit 7.08% 7.85% 9.71%
Depreciation & Amortization $145.0M $134.0M $60.00M
YoY Change 57.61% 123.33% 3.45%
% of Gross Profit 17.7% 17.82% 10.99%
Operating Expenses $543.0M $533.0M $407.0M
YoY Change 16.77% 30.96% 14.33%
Operating Profit $253.0M $209.0M $131.0M
YoY Change 36.02% 59.54% 18.02%
Interest Expense $11.00M $14.00M $9.000M
YoY Change -191.67% 55.56% -30.77%
% of Operating Profit 4.35% 6.7% 6.87%
Other Income/Expense, Net $4.000M $6.000M $4.000M
YoY Change -42.86% 50.0% -500.0%
Pretax Income $247.0M $196.0M $126.0M
YoY Change 116.67% 55.56% 28.57%
Income Tax $53.00M $43.00M $27.00M
% Of Pretax Income 21.46% 21.94% 21.43%
Net Earnings $194.0M $153.0M $99.00M
YoY Change 110.87% 54.55% 20.73%
Net Earnings / Revenue 8.94% 7.53% 6.84%
Basic Earnings Per Share $0.80 $0.63 $0.55
Diluted Earnings Per Share $0.80 $0.63 $0.54
COMMON SHARES
Basic Shares Outstanding 242.4M shares 241.8M shares 180.3M shares
Diluted Shares Outstanding 243.5M shares 243.0M shares 181.3M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $815.0M $947.0M $837.0M
YoY Change 15.11% 13.14% -25.07%
Cash & Equivalents $815.0M $947.0M $837.0M
Short-Term Investments
Other Short-Term Assets $234.0M $266.0M $193.0M
YoY Change 4.0% 37.82% 3.76%
Inventory $1.057B $1.039B $857.0M
Prepaid Expenses
Receivables $1.675B $1.641B $1.123B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.781B $3.893B $3.010B
YoY Change 1.23% 29.34% -3.46%
LONG-TERM ASSETS
Property, Plant & Equipment $1.144B $1.141B $631.0M
YoY Change 0.0% 80.82% -0.79%
Goodwill $7.509B $7.509B $2.738B
YoY Change 5.64% 174.25% -1.58%
Intangibles $2.374B $2.454B $915.0M
YoY Change -25.53% 168.2% -8.68%
Long-Term Investments
YoY Change
Other Assets $957.0M $927.0M $646.0M
YoY Change 3.8% 43.5% -5.14%
Total Long-Term Assets $11.98B $12.03B $4.930B
YoY Change -3.06% 144.04% -3.35%
TOTAL ASSETS
Total Short-Term Assets $3.781B $3.893B $3.010B
Total Long-Term Assets $11.98B $12.03B $4.930B
Total Assets $15.77B $15.92B $7.940B
YoY Change -2.06% 100.55% -3.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $940.0M $948.0M $710.0M
YoY Change -2.89% 33.52% 8.9%
Accrued Expenses $1.085B $1.098B $784.0M
YoY Change 74.44% 40.05% 9.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $17.00M $285.0M
YoY Change -89.7%
Total Short-Term Liabilities $2.042B $2.331B $1.494B
YoY Change -10.52% 56.02% -22.19%
LONG-TERM LIABILITIES
Long-Term Debt $1.981B $1.985B $1.881B
YoY Change -12.62% 5.53% 0.16%
Other Long-Term Liabilities $842.0M $847.0M $761.0M
YoY Change -6.44% 11.3% -18.35%
Total Long-Term Liabilities $1.981B $1.985B $1.881B
YoY Change -37.45% 5.53% 0.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.042B $2.331B $1.494B
Total Long-Term Liabilities $1.981B $1.985B $1.881B
Total Liabilities $5.417B $5.721B $4.351B
YoY Change -12.6% 31.49% -13.21%
SHAREHOLDERS EQUITY
Retained Earnings $2.774B $2.667B $2.331B
YoY Change 18.34% 14.41% 6.88%
Common Stock $8.663B $8.621B $2.154B
YoY Change 1.94% 300.23% 2.52%
Preferred Stock
YoY Change
Treasury Stock (at cost) $751.0M $748.0M $716.0M
YoY Change 4.74% 4.47% 1.27%
Treasury Stock Shares
Shareholders Equity $10.34B $10.20B $3.578B
YoY Change
Total Liabilities & Shareholders Equity $15.77B $15.92B $7.940B
YoY Change -2.06% 100.55% -3.39%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $194.0M $153.0M $99.00M
YoY Change 110.87% 54.55% 20.73%
Depreciation, Depletion And Amortization $145.0M $134.0M $60.00M
YoY Change 57.61% 123.33% 3.45%
Cash From Operating Activities $288.0M $89.00M -$19.00M
YoY Change 928.57% -568.42% -76.54%
INVESTING ACTIVITIES
Capital Expenditures $73.00M $74.00M $49.00M
YoY Change 35.19% 51.02% -200.0%
Acquisitions
YoY Change
Other Investing Activities -$4.000M $0.00 $1.000M
YoY Change -98.99% -100.0% -116.67%
Cash From Investing Activities -$77.00M -$51.00M -$37.00M
YoY Change -82.96% 37.84% -13.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $5.000M $0.00
YoY Change
Cash From Financing Activities -337.0M -$82.00M -$63.00M
YoY Change -213.09% 30.16% -40.57%
NET CHANGE
Cash From Operating Activities 288.0M $89.00M -$19.00M
Cash From Investing Activities -77.00M -$51.00M -$37.00M
Cash From Financing Activities -337.0M -$82.00M -$63.00M
Net Change In Cash -126.0M -$72.00M -$107.0M
YoY Change 0.0% -32.71% -53.88%
FREE CASH FLOW
Cash From Operating Activities $288.0M $89.00M -$19.00M
Capital Expenditures $73.00M $74.00M $49.00M
Free Cash Flow $215.0M $15.00M -$68.00M
YoY Change -926.92% -122.06% 112.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
474000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
354000000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59000000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2033000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1448000000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
1281000000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
902000000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
752000000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
546000000 usd
CY2024Q1 xyl Restructuring And Asset Impairment Losses
RestructuringAndAssetImpairmentLosses
10000000 usd
CY2023Q1 xyl Restructuring And Asset Impairment Losses
RestructuringAndAssetImpairmentLosses
8000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
209000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
131000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
14000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
9000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-5000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
196000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
126000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
153000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
99000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
241900000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180400000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
243000000.0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181300000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
153000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
99000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-65000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
22000000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-3000000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
4000000 usd
CY2024Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
1000000 usd
CY2023Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
5000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
-1000000 usd
CY2024Q1 xyl Other Comprehensive Income Loss Foreign Exchange For Pension And Non Pension Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossForeignExchangeForPensionAndNonPensionPostretirementBenefitPlansBeforeTax
2000000 usd
CY2023Q1 xyl Other Comprehensive Income Loss Defined Benefit Plan Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-65000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
30000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
11000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-5000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-76000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
35000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
77000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
134000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
947000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1019000000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
46000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
56000000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1641000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1617000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
1039000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1018000000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
266000000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
230000000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
3893000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3884000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1141000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1169000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
7509000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
7587000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2454000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2529000000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
927000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
943000000 usd
CY2024Q1 us-gaap Assets
Assets
15924000000 usd
CY2023Q4 us-gaap Assets
Assets
16112000000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
948000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
968000000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1098000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1221000000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
285000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
16000000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2331000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2205000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1985000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2268000000 usd
CY2024Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
323000000 usd
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
344000000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
558000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
557000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
524000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
562000000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
5721000000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5936000000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000.0 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000.0 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
258600000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
257600000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
3000000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3000000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8618000000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8564000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2667000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2601000000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
16100000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
16000000.0 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
748000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
733000000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-345000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-269000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
10195000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10166000000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
8000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
10000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10203000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10176000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15924000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16112000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
153000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
99000000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
61000000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
28000000 usd
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
73000000 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
32000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
18000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12000000 usd
CY2024Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
10000000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
8000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-5000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3000000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
11000000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
6000000 usd
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
47000000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
28000000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
52000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
55000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-14000000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-125000000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-98000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
89000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19000000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
74000000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
49000000 usd
CY2024Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
11000000 usd
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2000000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2000000 usd
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2000000 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2024Q1 us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
11000000 usd
CY2023Q1 us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
11000000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8000000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
33000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
88000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
60000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-82000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-63000000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-28000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-72000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-107000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1019000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
944000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
947000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
837000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
13000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
11000000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
39000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
49000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1910000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1383000000 usd
CY2024Q1 xyl Other Revenues
OtherRevenues
123000000 usd
CY2023Q1 xyl Other Revenues
OtherRevenues
65000000 usd
CY2024Q1 us-gaap Revenues
Revenues
2033000000 usd
CY2023Q1 us-gaap Revenues
Revenues
1448000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1910000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1383000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1910000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1383000000 usd
CY2022Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
151000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
183000000 usd
CY2023Q1 xyl Contract With Customer Asset New Contract Additions
ContractWithCustomerAssetNewContractAdditions
48000000 usd
CY2023Q1 xyl Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
58000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-50000000 usd
CY2023Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
48000000 usd
CY2023Q1 xyl Contract With Customer Asset Other
ContractWithCustomerAssetOther
0 usd
CY2023Q1 xyl Contract With Customer Liability Other
ContractWithCustomerLiabilityOther
0 usd
CY2024Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
151000000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
191000000 usd
CY2023Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
263000000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
315000000 usd
CY2024Q1 xyl Contract With Customer Asset New Contract Additions
ContractWithCustomerAssetNewContractAdditions
99000000 usd
CY2024Q1 xyl Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
178000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-161000000 usd
CY2024Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
100000000 usd
CY2024Q1 xyl Contract With Customer Asset Other
ContractWithCustomerAssetOther
-2000000 usd
CY2024Q1 xyl Contract With Customer Liability Other
ContractWithCustomerLiabilityOther
-10000000 usd
CY2023Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
260000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
322000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
978000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P60M
CY2024Q1 us-gaap Severance Costs1
SeveranceCosts1
9000000 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
6000000 usd
CY2024Q1 xyl Restructuring Reserve Asset Impairment Costs
RestructuringReserveAssetImpairmentCosts
1000000 usd
CY2023Q1 xyl Restructuring Reserve Asset Impairment Costs
RestructuringReserveAssetImpairmentCosts
0 usd
CY2024Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-1000000 usd
CY2023Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
0 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
9000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
6000000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2000000 usd
CY2024Q1 xyl Asset Impairmentand Restructuring Charges
AssetImpairmentandRestructuringCharges
10000000 usd
CY2023Q1 xyl Asset Impairmentand Restructuring Charges
AssetImpairmentandRestructuringCharges
8000000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
24000000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
10000000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
9000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
6000000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
11000000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
6000000 usd
CY2024Q1 xyl Restructuring Reserve Asset Impairment
RestructuringReserveAssetImpairment
1000000 usd
CY2023Q1 xyl Restructuring Reserve Asset Impairment
RestructuringReserveAssetImpairment
0 usd
CY2024Q1 us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
-1000000 usd
CY2023Q1 us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
0 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
20000000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
10000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.218
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.217
CY2022Q2 us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
833000000 sek
CY2022Q2 us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
78000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
153000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
99000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
241826000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
180371000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
28000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
25000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
241854000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180396000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
243021000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181319000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
367000000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
355000000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
112000000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
102000000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
560000000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
561000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
1039000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1018000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
7587000000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-78000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
7509000000 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3601000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1147000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2454000000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3617000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1088000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2529000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
73000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000000 usd
CY2024Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
3000000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
293000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
403000000 usd
CY2024Q1 xyl Customer Related Liabilities Current
CustomerRelatedLiabilitiesCurrent
379000000 usd
CY2023Q4 xyl Customer Related Liabilities Current
CustomerRelatedLiabilitiesCurrent
370000000 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
144000000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
170000000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
104000000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
106000000 usd
CY2024Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
43000000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
45000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
135000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
127000000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1098000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1221000000 usd
CY2024Q1 xyl Purchase Obligation Supplier Finance Program Termination Notice Required
PurchaseObligationSupplierFinanceProgramTerminationNoticeRequired
P30D
CY2024Q1 us-gaap Purchase Obligation
PurchaseObligation
262000000 usd
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
176000000 usd
CY2023Q4 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
176000000 usd
CY2024Q1 us-gaap Supplier Finance Program Obligation Increase
SupplierFinanceProgramObligationIncrease
281000000 usd
CY2024Q1 us-gaap Supplier Finance Program Obligation Decrease Settlement
SupplierFinanceProgramObligationDecreaseSettlement
193000000 usd
CY2024Q1 us-gaap Supplier Finance Program Obligation Period Increase Decrease
SupplierFinanceProgramObligationPeriodIncreaseDecrease
-2000000 usd
CY2024Q1 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
262000000 usd
CY2024Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
17000000 usd
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
17000000 usd
CY2024Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2270000000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2284000000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
285000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
16000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1985000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2268000000 usd
CY2024Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
4000000 usd
CY2023Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
3000000 usd
CY2024Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
4000000 usd
CY2023Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
5000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10176000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
153000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-76000000 usd
CY2023Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-2000000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
CY2023Q3 us-gaap Dividends Cash
DividendsCash
87000000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10203000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3503000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
99000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
35000000 usd
CY2022Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
2000000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.33
CY2022Q3 us-gaap Dividends Cash
DividendsCash
60000000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3589000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
18000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12000000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
33000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
2700000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5500000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2150000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
69.34
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
97000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
177000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
127.94
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
636000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
51.72
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1691000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
81.95
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
80000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1254000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
73.48
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M24D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
70000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1630000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
80.85
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y6M
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
79000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
46000000 usd
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
15000000 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
18000000 usd
CY2024Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
733000000 usd
CY2023Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
729000000 usd
CY2024Q1 us-gaap Accrual For Environmental Loss Contingencies Gross
AccrualForEnvironmentalLossContingenciesGross
4000000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
63000000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
54000000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
9000000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
6000000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
9000000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6000000 usd
CY2024Q1 xyl Standard Product Warranty Accrual Other
StandardProductWarrantyAccrualOther
1000000 usd
CY2023Q1 xyl Standard Product Warranty Accrual Other
StandardProductWarrantyAccrualOther
-1000000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
62000000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
55000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2024Q1 us-gaap Revenues
Revenues
2033000000 usd
CY2023Q1 us-gaap Revenues
Revenues
1448000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
209000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
131000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
14000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
9000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-5000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
196000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
126000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
134000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
60000000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
74000000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
49000000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001524472-24-000015-index-headers.html Edgar Link pending
0001524472-24-000015-index.html Edgar Link pending
0001524472-24-000015.txt Edgar Link pending
0001524472-24-000015-xbrl.zip Edgar Link pending
a101-cerwinkaofferletterap.htm Edgar Link pending
a102-2024nqgrantagreementf.htm Edgar Link pending
a103-2024nqgrantagreementf.htm Edgar Link pending
a104-2024psugrantagreement.htm Edgar Link pending
a105-2024psugrantagreement.htm Edgar Link pending
a106-2024rsugrantagreement.htm Edgar Link pending
a107-2024rsugrantagreement.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xyl-20240331.htm Edgar Link pending
xyl-20240331.xsd Edgar Link pending
xyl03312024ex311.htm Edgar Link pending
xyl03312024ex312.htm Edgar Link pending
xyl03312024ex321.htm Edgar Link pending
xyl03312024ex322.htm Edgar Link pending
xyl-20240331_def.xml Edgar Link unprocessable
xyl-20240331_lab.xml Edgar Link unprocessable
xyl-20240331_htm.xml Edgar Link completed
xyl-20240331_cal.xml Edgar Link unprocessable
xyl-20240331_pre.xml Edgar Link unprocessable